Global and United States Pandemic Influenza Vaccine Market Report & Forecast 2022-2028

Global and United States Pandemic Influenza Vaccine Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Global Pandemic Influenza Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pandemic Influenza Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pandemic Influenza Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Pandemic Influenza Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pandemic Influenza Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pandemic Influenza Vaccine Sales in Volume for the Year 2017-2028
1.4 Pandemic Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pandemic Influenza Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pandemic Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pandemic Influenza Vaccine Market Dynamics
1.5.1 Pandemic Influenza Vaccine Industry Trends
1.5.2 Pandemic Influenza Vaccine Market Drivers
1.5.3 Pandemic Influenza Vaccine Market Challenges
1.5.4 Pandemic Influenza Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pandemic Influenza Vaccine Market Segment by Type
2.1.1 Whole Virus Vaccines
2.1.2 Split Virus Vaccines
2.1.3 Subunit Vaccines
2.2 Global Pandemic Influenza Vaccine Market Size by Type
2.2.1 Global Pandemic Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pandemic Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pandemic Influenza Vaccine Market Size by Type
2.3.1 United States Pandemic Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pandemic Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pandemic Influenza Vaccine Market Segment by Application
3.1.1 For Children (6 months to 3 years)
3.1.2 For Adults and Children over 3 years
3.2 Global Pandemic Influenza Vaccine Market Size by Application
3.2.1 Global Pandemic Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pandemic Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pandemic Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pandemic Influenza Vaccine Market Size by Application
3.3.1 United States Pandemic Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pandemic Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pandemic Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pandemic Influenza Vaccine Competitor Landscape by Company
4.1 Global Pandemic Influenza Vaccine Market Size by Company
4.1.1 Top Global Pandemic Influenza Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Pandemic Influenza Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Pandemic Influenza Vaccine Price by Manufacturer (2017-2022)
4.2 Global Pandemic Influenza Vaccine Concentration Ratio (CR)
4.2.1 Pandemic Influenza Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pandemic Influenza Vaccine in 2021
4.2.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Pandemic Influenza Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pandemic Influenza Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pandemic Influenza Vaccine Market Size by Company
4.5.1 Top Pandemic Influenza Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pandemic Influenza Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pandemic Influenza Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Pandemic Influenza Vaccine Market Size by Region
5.1 Global Pandemic Influenza Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pandemic Influenza Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Pandemic Influenza Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Pandemic Influenza Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pandemic Influenza Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Pandemic Influenza Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Pandemic Influenza Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pandemic Influenza Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pandemic Influenza Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pandemic Influenza Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pandemic Influenza Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pandemic Influenza Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pandemic Influenza Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CSL
7.1.1 CSL Corporation Information
7.1.2 CSL Description and Business Overview
7.1.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL Pandemic Influenza Vaccine Products Offered
7.1.5 CSL Recent Development
7.2 GSK
7.2.1 GSK Corporation Information
7.2.2 GSK Description and Business Overview
7.2.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GSK Pandemic Influenza Vaccine Products Offered
7.2.5 GSK Recent Development
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Corporation Information
7.3.2 Sanofi Pasteur Description and Business Overview
7.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Products Offered
7.3.5 Sanofi Pasteur Recent Development
7.4 Mylan
7.4.1 Mylan Corporation Information
7.4.2 Mylan Description and Business Overview
7.4.3 Mylan Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Mylan Pandemic Influenza Vaccine Products Offered
7.4.5 Mylan Recent Development
7.5 AstraZeneca
7.5.1 AstraZeneca Corporation Information
7.5.2 AstraZeneca Description and Business Overview
7.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
7.5.5 AstraZeneca Recent Development
7.6 Pfizer
7.6.1 Pfizer Corporation Information
7.6.2 Pfizer Description and Business Overview
7.6.3 Pfizer Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Pfizer Pandemic Influenza Vaccine Products Offered
7.6.5 Pfizer Recent Development
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporation Information
7.7.2 Johnson & Johnson Description and Business Overview
7.7.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Johnson & Johnson Pandemic Influenza Vaccine Products Offered
7.7.5 Johnson & Johnson Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pandemic Influenza Vaccine Industry Chain Analysis
8.2 Pandemic Influenza Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pandemic Influenza Vaccine Distributors
8.3 Pandemic Influenza Vaccine Production Mode & Process
8.4 Pandemic Influenza Vaccine Sales and Marketing
8.4.1 Pandemic Influenza Vaccine Sales Channels
8.4.2 Pandemic Influenza Vaccine Distributors
8.5 Pandemic Influenza Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Pandemic Influenza Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pandemic Influenza Vaccine Market Trends
Table 3. Pandemic Influenza Vaccine Market Drivers
Table 4. Pandemic Influenza Vaccine Market Challenges
Table 5. Pandemic Influenza Vaccine Market Restraints
Table 6. Global Pandemic Influenza Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pandemic Influenza Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pandemic Influenza Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pandemic Influenza Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pandemic Influenza Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pandemic Influenza Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pandemic Influenza Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pandemic Influenza Vaccine Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Pandemic Influenza Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Pandemic Influenza Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2021)
Table 18. Top Players of Pandemic Influenza Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pandemic Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pandemic Influenza Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pandemic Influenza Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pandemic Influenza Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pandemic Influenza Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Pandemic Influenza Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pandemic Influenza Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Pandemic Influenza Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Pandemic Influenza Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pandemic Influenza Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Pandemic Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pandemic Influenza Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Pandemic Influenza Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Pandemic Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Pandemic Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Pandemic Influenza Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CSL Corporation Information
Table 43. CSL Description and Business Overview
Table 44. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. CSL Pandemic Influenza Vaccine Product
Table 46. CSL Recent Development
Table 47. GSK Corporation Information
Table 48. GSK Description and Business Overview
Table 49. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. GSK Product
Table 51. GSK Recent Development
Table 52. Sanofi Pasteur Corporation Information
Table 53. Sanofi Pasteur Description and Business Overview
Table 54. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Sanofi Pasteur Product
Table 56. Sanofi Pasteur Recent Development
Table 57. Mylan Corporation Information
Table 58. Mylan Description and Business Overview
Table 59. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. Mylan Product
Table 61. Mylan Recent Development
Table 62. AstraZeneca Corporation Information
Table 63. AstraZeneca Description and Business Overview
Table 64. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. AstraZeneca Product
Table 66. AstraZeneca Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Johnson & Johnson Corporation Information
Table 73. Johnson & Johnson Description and Business Overview
Table 74. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Johnson & Johnson Product
Table 76. Johnson & Johnson Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Pandemic Influenza Vaccine Customers List
Table 80. Pandemic Influenza Vaccine Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pandemic Influenza Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Pandemic Influenza Vaccine Sales 2017-2028 (K Doses)
Figure 5. United States Pandemic Influenza Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pandemic Influenza Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Pandemic Influenza Vaccine Sales 2017-2028 (K Doses)
Figure 8. United States Pandemic Influenza Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pandemic Influenza Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Pandemic Influenza Vaccine Report Years Considered
Figure 11. Product Picture of Whole Virus Vaccines
Figure 12. Product Picture of Split Virus Vaccines
Figure 13. Product Picture of Subunit Vaccines
Figure 14. Global Pandemic Influenza Vaccine Market Share by Type in 2022 & 2028
Figure 15. Global Pandemic Influenza Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Pandemic Influenza Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Pandemic Influenza Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 18. Global Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Pandemic Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 20. United States Pandemic Influenza Vaccine Market Share by Type in 2022 & 2028
Figure 21. United States Pandemic Influenza Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Pandemic Influenza Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Pandemic Influenza Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 24. United States Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Pandemic Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 26. Product Picture of For Children (6 months to 3 years)
Figure 27. Product Picture of For Adults and Children over 3 years
Figure 28. Global Pandemic Influenza Vaccine Market Share by Application in 2022 & 2028
Figure 29. Global Pandemic Influenza Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Pandemic Influenza Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Pandemic Influenza Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 32. Global Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Pandemic Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 34. United States Pandemic Influenza Vaccine Market Share by Application in 2022 & 2028
Figure 35. United States Pandemic Influenza Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Pandemic Influenza Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Pandemic Influenza Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 38. United States Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Pandemic Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 40. North America Pandemic Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 41. North America Pandemic Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Pandemic Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 45. Europe Pandemic Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Pandemic Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 52. Asia-Pacific Pandemic Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Pandemic Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 64. Latin America Pandemic Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Pandemic Influenza Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 69. Middle East & Africa Pandemic Influenza Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Pandemic Influenza Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Pandemic Influenza Vaccine Value Chain
Figure 74. Pandemic Influenza Vaccine Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs